The extent to which vitamin E (alpha-tocopherol) intake early in childhood is associated with alanine aminotransferase (ALT) level later in childhood is unknown. The objective of this research is to test the hypothesis that higher alpha-tocopherol intake during early childhood is associated with lower odds of elevated ALT levels during mid-childhood and to examine how body mass index (BMI) influences these relationships. We studied 528 children in Project Viva. Mothers reported child dietary intake at early childhood visits (median 3.1 years) using a validated food frequency questionnaire. At mid-childhood (median 7.6 years), we collected child blood and anthropometric data. The main outcome was elevated sex-specific mid-childhood ALT level (22.1 U/L for female children and 25.8 U/L for male children). In multivariable logistic regression models, we assessed the association of energy-adjusted alpha-tocopherol intake with ALT levels, adjusting for child age, sex, race/ethnicity, diet, and age-adjusted sex-specific BMI z-score at mid-childhood. Among children in this study, 48% were female, 63% were non-Hispanic white, 19% were non-Hispanic black, and 4% were Hispanic/Latino. Mean alpha-tocopherol intake was 3.7 6 1.0 mg/day (range, 1.4-9.2) at early childhood. At mid-childhood, mean BMI z-score was 0.41 6 1.0 units and 22% had an elevated ALT level. In multivariable-adjusted logistic regression models, children with higher early childhood vitamin E intake had lower odds of elevated mid-childhood ALT (adjusted odds ratio [AOR], 0.62; 95% confidence interval [CI], 0.39, 0.99) for quartiles 2-4 compared with the lowest quartile of intake. Findings persisted after accounting for early childhood diet (AOR, 0.62; 95% CI, 0.36, 1.08) and were strengthened after additionally accounting for mid-childhood BMI z-score (AOR, 0.56; 95% CI, 0.32, 0.99). Conclusion: In this cohort, higher early childhood intake of alpha-tocopherol was associated with lower odds of elevated midchildhood ALT level. (HEPATOLOGY 2018;67:1339-1347.
N onalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children, and the prevalence of pediatric NAFLD has increased rapidly over the past 2 decades.
(1) NAFLD encompasses a variety of disease phenotypes, including simple steatosis, steatohepatitis, and fibrosis; the hallmark of each is hepatic steatosis (fat infiltration of liver cells) without alternative causes. (2) An estimated 40% of children with overweight (sex-specific body mass index [BMI] 85 th Abbreviations: ALT, alanine aminotransferase; AOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; NAFLD, nonalcoholic fatty liver disease; OR, odds ratio; TONIC, Treatment of Nonalcoholic Fatty Liver Disease in Children.
and <95
th percentile for age) or obesity (BMI 95 th percentile) and around 1 in 10 children age 2-19 years of all weight categories have NAFLD. (1, 3, 4) In crosssectional pediatric studies, older age, race/ethnicity, and male sex are risk factors. (3, (5) (6) (7) Long-term complications may include cirrhosis and hepatocellular carcinoma, and NAFLD has emerged as the most rapidly growing cause of hepatocellular carcinoma requiring liver transplantation among adults in the United States. (8) Expert committees have recommended use of serum alanine aminotransferase (ALT) levels to screen for NAFLD among at-risk children. (9, 10) In adults of all BMI categories, continuous increases in serum ALT levels are associated with hepatocellular carcinoma risk, type 2 diabetes risk, and mortality. (11) Among children ages 12-19 years, thresholds for serum ALT 25.8 U/ L for male children and 22.1 for female children show 80%-92% sensitivity and 79%-85% specificity to detect pediatric NAFLD and have been used in epidemiologic studies to estimate the prevalence of NAFLD. (12, 20) Given the high proportion of adolescents with elevated plasma ALT levels, (1) early and mid-childhood could be key windows of opportunity to prevent rising ALT levels. Moreover, identifying protective factors against elevated ALT levels could inform future interventions to prevent pediatric NAFLD. Yet, little information exists on etiologies of elevated ALT levels during childhood.
Vitamin E is a prime candidate for protection against development of NAFLD because its antioxidant properties may combat lipotoxic effects of free fatty acids and metabolites, which play a role in hepatocellular damage. Among children and adolescents with biopsy-proven steatohepatitis, higher intake of the alpha-tocopherol isoform of vitamin E had a crosssectional correlation with lower degree of steatosis, and alpha-tocopherol supplementation improved histologic outcomes in a randomized controlled trial. (1, 13) Identifying the prospective association of alpha-tocopherol intake during early childhood with later ALT levels could inform future efforts to prevent liver damage in children.
The overall goal of this research was to prospectively examine the relationship of alpha-tocopherol intake during early childhood with subsequent ALT levels and to ascertain the extent to which mid-childhood adiposity mediates this relationship. We hypothesized that higher intake of alpha-tocopherol during early childhood would be associated with lower odds of elevated ALT levels later in childhood and that this relationship would operate independent of the child ageand sex-specific BMI z-score.
Methods

STUDY DESIGN AND PARTICIPANTS
We studied children in Project Viva, an ongoing prospective prebirth cohort study. Pregnant women were recruited from Atrius Harvard Vanguard Medical Associates, a multispecialty group practice in eastern Massachusetts. Study recruitment and retention details are described elsewhere. (14) Mothers gave written informed consent at enrollment in pregnancy and at in-person visits when their children were in early (median child age 3.1 years) and mid-childhood (median child age 7.6 years); children gave verbal assent at mid-childhood. The institutional review board of Harvard Pilgrim Health Care approved all study protocols.
Of the 2,128 live singleton births in the cohort, 1,708 remained enrolled and thus were eligible for a mid-childhood study visit, and 1,116 attended an
in-person visit between age 6 and 10 years. Of those, 635 had blood available for ALT analysis, 534 of those had information on early childhood dietary intake, and 528 of those had information on BMI z-score at midchildhood; these 528 form the study population for this analysis. Characteristics of the study sample of 528 were similar to the 588 who attended a mid-childhood visit but did not have blood available for ALT analysis in terms of maternal age and prepregnancy BMI, child sex, and BMI z-score at mid-childhood (data not shown). However, compared to children with mid-childhood visits not included in this analysis, children in our study sample had slightly lower mean age at early (38.3 6 2.7 months versus 39.1 6 4.9 months) and mid-childhood (94.2 6 8.9 months versus 97.7 6 11.5 months) visits.
MEASUREMENTS
Main Exposure: Early Childhood AlphaTocopherol Intake Vitamin E intake measured as alpha-tocopherol during early childhood was the main exposure. At early childhood visits, parents reported children's dietary intake by completing a semiquantitative food frequency questionnaire that was validated for use in preschool-aged children, including for measurement of alpha-tocopherol intake. (15) Questions assessed usual frequency of intake of specific food and drink. We calculated nutrient intakes using the Harvard nutrient composition database, which is based primarily on U.S. Department of Agriculture information and is continually supplemented by other published sources. (16) (17) (18) We estimated energy-adjusted total daily alpha-tocopherol intake from foods by using the nutrient residual method. We categorized alphatocopherol intake during early childhood into quartiles based on the sample of children with available alphatocopherol intake information. We defined insufficient alpha-tocopherol intake based on age-specific recommended daily allowance for alpha-tocopherol. (19) The current recommended daily allowance for natural alphatocopherol is 6 mg for children age 1-3 years and 7 mg for children age 4-8 years. However, because self-reported insufficient alpha-tocopherol intake has high prevalence nationally, (19) we additionally defined low alphatocopherol intake as the lowest quartile (<2.98 mg/day).
Main Outcome: Mid-Childhood ALT Level
We collected blood samples from children at the mid-childhood visit. Samples were processed within 24 hours and frozen at -808C until the time of analysis. We measured the concentration of ALT by enzymatic assay on the Roche P Modular system using Roche reagents (Roche Diagnostics, Indianapolis, IN). This assay is approved by the U.S. Food and Drug Administration for clinical use and is standardized across centers. The lowest detection limit of this assay is 4 U/L, and the day-to-day imprecision values at concentrations of 42, 55, and 130 U/L are 4.4, 3.7, and 3.3%, respectively. We classified elevated ALT levels as 25.8 U/L for male children and 22.1 for female children. (1, 12) Covariates At recruitment during pregnancy, we collected information including maternal age, education, parity and prepregnancy weight and height, and paternal weight and height. Child sex was documented at delivery. At early childhood, we collected information about marital status, household income, and child race/ethnicity. We also collected data on diet and physical activity factors at early childhood that could act as confounders of the relationship between alpha-tocopherol intake and ALT level. As described above for alphatocopherol intake, mothers provided information on child diet using a semiquantitative validated food frequency questionnaire. Based on existing literature on dietary factors that could be related to NAFLD in children, (20, 21) we estimated daily intakes of fruit and vegetable, sugar-sweetened beverages, total energy intake in calories, and energy-adjusted total fat, carbohydrates, protein, saturated fat, polyunsaturated fat, fructose, vitamin D, and vitamin C intake by using the nutrient residual method. (15) Mothers reported child moderate-to-vigorous daily physical activity at early childhood. (22) 
Potential Intermediates
We examined mid-childhood BMI z-score as a potential intermediate of the relationship with alphatocopherol intake. We measured height and weight of children by using a calibrated stadiometer (Shorr Productions, Olney, MD) and scale (Seca Model 881; Seca Corporation, Hanover, MD). We calculated ageand sex-specific BMI z-scores using Centers for Disease Control and Prevention 2000 growth reference data. (23) Research assistants followed standardized techniques for measurements and participated in inservice training to ensure measurement validity (provided by IJ Shorr, Shorr Productions, Olney, MD). (24) Inter-rater and intra-rater measurement errors were within published reference ranges for all measurements. (25) 
STATISTICAL ANALYSIS
We first examined the bivariate relationships of alpha-tocopherol intake with other covariates and the main outcome. We used logistic regression models to assess the effect of low alpha-tocopherol intake at early childhood with high ALT level at mid-childhood. We also examined the relationship between each quartile of alpha-tocopherol intake and ALT outcomes. In multivariable models, we included only those covariates that were of a priori interest based on the literature. The covariate-adjusted model included child age, sex, and race/ethnicity. In subsequent models, we additionally adjusted for individual dietary factors that had a statistically significant correlation (P > 0.01) with vitamin E intake at early childhood and could therefore act as confounders of the association between alphatocopherol and ALT level. The diet-adjusted model included fruit, vegetable, energy-adjusted saturated fat, energy-adjusted polyunsaturated fat, fructose, vitamin D, and vitamin C intake at early childhood. To account for the potential intermediate of the BMI z-score at mid-childhood, we additionally adjusted the covariate-adjusted and the diet-adjusted models for the mid-childhood BMI z-score.
Because ALT levels differ between male and female individuals, we also investigated whether sex modified the effect estimate of early childhood alpha-tocopherol intake and mid-childhood elevated ALT level. We conducted all of the analyses using SAS version 9.4 (SAS Institute, Inc., Cary, NC).
Results
Family and child characteristics of our study group are shown in Table 1 . Of the 528 children included in our analyses, 48% were female, 63% were nonHispanic white, 19% were non-Hispanic black, 4% were Hispanic/Latino, and 2% were Asian. At early (11) 16 (12) 17 (13) 16 (12) Data from 528 mother-child pairs. *All estimates of vitamin E (alpha-tocopherol) intake were adjusted for total energy intake using the nutrient residual method.
childhood, fruit and vegetable intake and energyadjusted saturated fat, polyunsaturated fat, fructose, vitamin D, and vitamin C intake were correlated with vitamin E intake (P < 0.001). Sugar-sweetened beverage intake, calories, total fat, carbohydrate, and protein intake were not correlated with alpha-tocopherol intake at early childhood (data not shown). Total energy and energy-adjusted alpha-tocopherol intake during early childhood by midchildhood ALT category are shown in Table 2 . At mid-childhood, 22% of children had elevated ALT levels; these children with high ALT levels had similar maternal-reported early childhood mean total energy intake as those with normal midchildhood ALT levels.
Results from logistic regression models testing our first hypothesis of the effects of early childhood alphatocopherol intake on mid-childhood ALT levels are presented in Table 3 . In unadjusted models, those with higher alpha-tocopherol intake (quartiles 2-4) had lower odds of elevated ALT level (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.41, 1.02) compared to children with the lowest quartile of alpha-tocopherol intake. After adjusting for a priori confounders, these findings persisted (OR, 0.62; 95% CI, 0.39, 0.99). In models examining quartiles of alpha-tocopherol intake, children in the third quartile of alpha-tocopherol intake had lower odds of elevated ALT at mid-childhood compared to those with the lowest quartile of intake in unadjusted (OR, 0.48; 95% CI, 0.27, 0.88) and Data from 528 mother-child pairs. *Normal ALT defined as <22.1 U/L for female individuals and <25.8 U/L for male individuals. † All estimates of vitamin E (alpha-tocopherol) intake were adjusted for total energy intake using the nutrient residual method. Data from 528 children in Project Viva. Bold indicates statistically significant values where the 95% CI does not cross the null. *Covariate-adjusted model is adjusted for child sex, race/ethnicity, and age at time of mid-childhood visit. † Diet-adjusted model is covariate-adjusted model additionally adjusted for fruit and vegetable intake and energy-adjusted saturated fat, polyunsaturated fat, fructose, vitamin D, and vitamin C, at early childhood visit.
‡ BMIz-adjusted model is covariate-adjusted model additionally adjusted for child BMI z-score at mid-childhood visit. § Diet and BMIz-adjusted model is diet-adjusted model additionally adjusted for BMI z-score at mid-childhood visit. Abbreviation: BMIz, BMI z-score. child-adjusted (OR 0.43; 95% CI, 0.23,0.80) models. We also found lower odds of ALT elevation among children in the second and fourth quartiles of alphatocopherol intake compared to those with the lowest quartile of intake, but CIs were wide and included the null. We did not find any modification of the effect of alpha-tocopherol intake and ALT elevation by child sex (interaction P > 0.1 for all models).
We then examined the extent to which dietary factors correlated with alpha-tocopherol intake at early childhood accounted for the relationship between alpha-tocopherol intake and ALT elevation. In models adjusted for child age, sex, race/ethnicity, and individual dietary factors, we found that adjusting for vegetable, polyunsaturated fat, or vitamin D intake slightly attenuated the relationship between alphatocopherol intake at early childhood and elevated ALT at mid-childhood (Fig. 1) . After adjusting for fruit, saturated fat, fructose, or vitamin C intake, the association of higher alpha-tocopherol intake at early childhood with lower odds of elevated ALT at midchildhood persisted. In the diet-adjusted model, children with higher vitamin E intake (quartiles 2-4) had similar odds of elevated ALT level as in the covariateadjusted model, but CIs widened and crossed the null. In models examining the association of each quartile of alpha-tocopherol intake with elevated ALT level, findings were similar to the covariateadjusted model.
We next investigated our hypothesis that the relationship between early childhood alpha-tocopherol intake and elevated ALT level at mid-childhood would be independent of mid-childhood adiposity. The midchildhood BMI z-score was highest in the second and third quartiles of early childhood alpha-tocopherol intake ( Table 1) . We did not find a correlation between early childhood alpha-tocopherol intake and mid-childhood BMI z-score (Spearman r 5 0.06; P 5 0.15), but the BMI z-score had a cross-sectional correlation with ALT at mid-childhood (Spearman r 5 0.21; P <0.001). After adjusting our models of early childhood alpha-tocopherol intake and mid-childhood elevated ALT for mid-childhood BMI z-score, we found lower ORs with narrower CIs for models comparing second to fourth quartiles to the lowest quartile of intake (OR, 0.55; 95% CI, 0.34, 0.89). In models comparing individual quartiles to the lowest quartile of alpha-tocopherol intake, adjusting for BMI z-score resulted in strengthening of associations of alphatocopherol quartile with ALT elevation (e.g., among children in the third versus first quartile of intake; OR 0.37; 95% CI, 0.20, 0.69).
In our final model adjusting for covariates, early childhood diet, and mid-childhood BMI z-score, findings persisted but CIs widened in models comparing second and fourth quartiles (OR, 0.56; 95% CI, 0.32, 0.99) to the lowest quartile as well as in models comparing individual quartiles to the lowest quartile of alpha-tocopherol intake.
Discussion
In this prospective cohort study, children with higher alpha-tocopherol intake during early childhood had a lower likelihood of elevated ALT levels at midchildhood. Overall, the relationship between higher alpha-tocopherol intake and lower odds of elevated ALT persisted after accounting for demographic and dietary confounders. Accounting for mid-childhood BMI z-score strengthened the relationship between higher alpha-tocopherol intake at early childhood and lower odds of ALT elevation at mid-childhood. Taken together, these findings suggest that appropriate levels of alpha-tocopherol intake could promote liver health later in childhood and that this relationship is not mediated by an effect of alpha-tocopherol intake on BMI.
Our study demonstrates a link between early childhood dietary risk factors and later childhood liver health. We prospectively examined a modifiable risk factor for elevated plasma ALT levels during midchildhood. Plasma or serum ALT levels are used to screen for pediatric NAFLD, a prevalent childhood obesity complication. Although little information on the natural history of NAFLD in children exists, fibrosis/cirrhosis and end-stage liver disease can occur even in childhood. Thus, identifying alpha-tocopherol as an early childhood protective factor against later elevation of ALT levels suggests that future interventions to study approaches to prevent development and progression of pediatric NAFLD should take early childhood alpha-tocopherol consumption into account. National data show that >90% of the U.S. population does not consume sufficient alpha-tocopherol; this led to the classification of vitamin E as a shortfall nutrient by the 2015 Dietary Guidelines Advisory Committee. (26) Given the high prevalence of both inadequate vitamin E consumption and NAFLD, our findings are relevant to the general U.S. population.
Lower alpha-tocopherol intake is a plausible risk factor for elevated ALT levels and NAFLD. Substantial evidence shows a link between intake of the fatsoluble antioxidant vitamin E and severity of NAFLD in children with biopsy-proven steatohepatitis. In a cross-sectional study of children with biopsy-proven steatohepatitis, intake of alpha-tocopherol was inversely related to steatosis grade. (20) In the multicenter placebo-controlled Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) trial, children with established NAFLD who received vitamin E as alpha-tocopherol 400 IU twice daily had improved histologic outcomes after 96 weeks but did not have a statistically significant improvement in ALT levels compared to the placebo group. (14) In the Pioglitazone versus Vitamin E versus Placebo in Nonalcoholic Steatohepatitis (PIVENS) randomized controlled trial, vitamin E supplementation improved ALT levels among adults regardless of whether they lost, gained, or maintained stable weight. (27) Thus, our results extend the existing literature showing an alphatocopherol treatment effect in established NAFLD to suggest that alpha-tocopherol intake early in childhood could have a protective role against liver injury later in childhood.
We hypothesized that the association between alpha-tocopherol intake and ALT would be independent of the BMI z-score. In a recent adult clinical trial, the presence of metabolic syndrome lowered the bioavailability of alpha-tocopherol after ingestion of doses compatible with the reference daily intake, suggesting that higher oxidative stress and inflammation increase alpha-tocopherol requirements. (28) However, in our study we found no relationship between early childhood alpha-tocopherol intake and mid-childhood BMI z-score. Children who are overweight or obese are more likely to have elevated ALT levels than children with a healthy weight, and we did find a relationship between mid-childhood BMI z-score and ALT level. Adjusting for mid-childhood BMI z-score resulted in a further reduction of odds of ALT elevation among children with higher alpha-tocopherol intake, suggesting that the beneficial effects of early childhood alpha-tocopherol intake were not mediated by mid-childhood BMI z-score.
In the TONIC trial, children received 400 IU (180 mg) of alpha-tocopherol twice daily. Our study sample had early childhood alpha-tocopherol intake, ranging from 1.4-9.2 mg, substantially below the supplemental amounts in the TONIC trial. Also, Vitamin E is present in foods that are more often consumed by those with healthful diets, such as wheat germ, almonds, spinach, and broccoli, as well as cooking oils, (26) and less often by young children. We included alphatocopherol intake from diet and supplements in our calculations but cannot distinguish the contribution of various foods or supplements to alpha-tocopherol intake.
The strengths of our study include the prospective nature of the design and its evaluation of a modifiable risk factor during a life course period that is important to prevention of pediatric NAFLD. However, we also note some limitations. Because this is a population-based cohort, we did not have liver imaging or liver tissue available for analysis, which limits our ability to determine grade and stage of liver disease. However, in clinical guidelines, ALT levels are the recommended test for NAFLD screening, and substantial evidence shows that higher ALT levels are linked to morbidity and mortality, supporting the importance of ALT levels as a health outcome. Second, we estimated vitamin E intake based on parental report of child diet, which could be prone to over or underestimation. Finally, we had small sample sizes of Asian and Hispanic children. Because these racial/ ethnic groups are more likely to have NAFLD compared to non-Hispanic white or black children, (1) our effect estimates may underestimate the association of alpha-tocopherol intake with circulating ALT levels.
In summary, we found that higher intake of the alpha-tocopherol isoform of vitamin E during early childhood was associated with lower odds of elevated ALT level during mid-childhood. Our findings suggest that modifiable risk factors, specifically intake of vitamin E, should be considered in future interventions to identify approaches to prevent pediatric NAFLD.
